Company Analysis

Cadre Holdings, Inc. (CDRE)

NYSE: CDRE · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Jacksonville, FL · filing with the SEC since 2021
Grade5.9
◀ Past 7.1● Present 5.8▶ Future 4.9

Filings

197 filings since 2017 beside 215 insider forms · Accelerated filer and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.

Filings a yearinsider forms included
457194727357
202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Jun 3, 2026.
Insider forms 215

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 4, 2026 10-Q Quarterly report Sep 30, 2026
Nov 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 30, 2026 SCHEDULE 13D/A Activist holder update, amended
Aug 7, 2026 EFFECT Registration effective
Aug 7, 2026 8-K/A items 2.02, 9.01 Results released · Current report, amended Aug 5, 2026
Aug 6, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 5, 2026 S-4/A Merger or exchange registration, amended
Aug 5, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 29, 2026 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Jul 23, 2026
Jun 18, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 3, 2026 8-K items 5.02, 5.07 Officer or director change; Shareholder vote · Current report May 29, 2026
May 29, 2026 SD Conflict minerals report
May 14, 2026 SCHEDULE 13G/A Large holder update, amended
May 14, 2026 DEFA14A Extra proxy material
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 8-K items 2.02, 9.01 Results released · Current report
May 6, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 24, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 24, 2026 DEF 14A Proxy statement May 29, 2026
Mar 31, 2026 S-3ASR Shelf registration
Mar 30, 2026 S-4 Merger or exchange registration
Mar 10, 2026 10-K Annual report Dec 31, 2025
Mar 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 12, 2026 SCHEDULE 13G Large holder notice
Feb 5, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 2, 2026 8-K/A items 1.01, 9.01 Major agreement signed · Current report, amended Oct 28, 2025
Nov 19, 2025 SCHEDULE 13D/A Activist holder update, amended
Nov 14, 2025 SCHEDULE 13D Activist holder notice
Nov 4, 2025 10-Q Quarterly report Sep 30, 2025
Nov 4, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 3, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report Oct 28, 2025
Oct 29, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 8, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 12, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 6, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 5, 2025 10-Q Quarterly report Jun 30, 2025
Aug 5, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 13, 2025 S-8 Employee stock plan registration
Jun 5, 2025 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report May 30, 2025
40 of 197 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CDRE · research, not advice